Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2026-02-24 @ 8:27 AM
Study NCT ID:
NCT00493220
Status:
COMPLETED
Last Update Posted:
2011-12-02
First Post:
2007-06-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration
Sponsor:
Baxter Healthcare Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2007-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-09
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-26
First Submit QC Date:
None
Study First Post Date:
2007-06-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-09-12
Results First Submit QC Date:
None
Results First Post Date:
2011-12-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-10-24
Last Update Post Date:
2011-12-02
Last Update Post Date Type:
ESTIMATED